Abstract
Connective tissue disorders have well-known ocular associations that may be presenting features of the disease or occur as complications during the course of the disorder. Keratoconjunctivitis sicca, keratitis, scleritis, uveitis, retinal vasculitis, choroidopathy, and their associations with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, psoriatic arthritis, juvenile idiopathic arthritis, and polymyositis are reviewed.
Similar content being viewed by others
References and Recommended Reading
Pepose JS, Akata RF, Pflugfelder SC, et al.: Mononuclear cell phenotypes and immunoglobulin gene rearrangement in lacrimal gland biopsies from patients with Sjogren’s syndrome. Ophthalmol 1990, 97:1599–1602.
Fox RI: Sjogren’s syndrome: evolving therapies. Expert Opin Investig Drugs 2003, 12:247–254. This is of interest to clinicians and scientists who are looking at novel therapies.
Frith P, Burge SM, Millard PR, Wojnarowska F: External ocular findings in lupus erythematosus: a clinical and immunohistopathological study. Br J Ophthalmol 1990, 74:163–167.
Noble BA, Loh RS, Maclennan S, et al.: Comparison of autologous serum eyedrops with conventional therapy in a random controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004, 88:647–652. This is of interest to clinicians and scientists who are looking at novel therapies.
Gao J, Morgan G, Tieu D, et al.: ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjogren’s syndrome-like MRL/lpr mice. Exp Eye Res 2004, 78:823–835.
Messmer EM, Foster CS: Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 1999, 43:379–396.
Squirrell DM, Winfield J, Amos RS: Peripheral ulcerative keratitis "corneal melt" and rheumatoid arthritis: a case series. Rheumatology (Oxford) 1999, 38:1245–1248.
Perez VL, Azar DT, Foster CS: Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease. Semin Ophthalmol 2002, 17:124–130.
Sainz de la Maza M, Foster CS, Jabbur NS: Scleritis associated with systemic diseases. Ophthalmol 1995, 102:687–692.
Sainz de la Maza M, Foster CS, Jabbur NS: Scleritis associated with rheumatoid arthritis and with other systemic immunemediated diseases. Ophthalmol 1994, 101:1281–1286.
Nguyen QD, Foster CS: Scleral patch grafting in the management of necrotizing scleritis. Int Ophthalmol Clin 1991, 39:109–131.
Edelston C, Reddy MA, Stanford MR, Graham EM: Visual loss associated with pediatric uveitis in English primary and referral centers. Am J Ophthalmol 2003, 135:676–680.
Tugal-Tutkun I, Havrilikova K, Power WJ, Foster CS: Changing patterns in uveitis in childhood. Ophthalmol 1996, 103:375–383.
Holland GN, Stiehm ER: Special considerations in the evaluation and management of uveitis in children. Am J Ophthalmol 2003, 135:867–878. An excellent review of a difficult and often complicated area of ophthalmic practice.
Foster CS: Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol 2003, 14:395–398.
Pato E, Banares A, Jover, et al.: Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis. J Rheumatol 2000, 27:2198–2202.
Anderson NG, Garcia-Valenzuela E, Martin DF: Hypopyon uveitis and relapsing polychondritis: a report of 2 patients and review of autoimmune hypopyon uveitis. Ophthalmology 2004, 111:1251–1254.
Martin TM, Smith JR, Rosenbaum JT: Anterior uveitis: current concepts of pathogenesis and interactions with the spondyloarthropathies. Curr Opin Rheumatol 2002, 14:337–341.
Martin TM, Rosenbaum JT: Identifying genes that cause disease: HLA-B27, the paradigm, the promise, the perplexity. Br J Ophthalmol 1998, 82:1354–1355.
Montehermoso A, Cervera R, Font J, et al.: Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum 1999, 28:326–332.
Snyers B, Lambert M, Hardy JP: Retinal and choroidal vasoocclusive disease in SLE associated with antiphospholipid antibodies. Retina 1990, 10:255–259.
Jabs DA, Fine SL, Hochberg MC, et al.: Severe retinal vasoocclusive disease in systemic lupus erythematosus. Arch Ophthalmol 1986, 104:558–563.
Nguyen QD, Uy HS, Akpek EK, et al.: Choroidopathy of systemic lupus erythematosus. Lupus 2000, 9:288–298.
Jabs DA, Hanneken AM, Schachat AD, et al.: Choroidopathy in systemic lupus erythematosus. Arch Ophthalmol 1998, 106:230–234.
Matsuo T, Nakayama T, Koyanani T, Matsuo U: Multifocal pigment epithelial damages with serous retinal detachment in systemic lupus erythematosus. Ophthalmologica 1987, 195:97–99.
Kinyoun JL, Kalina RE: Visual loss from choroidal ischemia. Am J Ophthalmol 1986, 101:650–656.
Aronson AJ, Ordonez NG, Diddie KR, Ernest JT: Immune-complex deposition in the eye in systemic lupus erythematosus. Arch Intern Med 1979, 139:1312–1313.
Au A, O’Day J: Review of the vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Exper Ophthalmol 2004, 32:87–100.
Cunningham ET, Alfred PR, Irvine AR: Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmol 1996, 103:2081–2090.
Khng CGYW, Yap EY, Au-Eong KG, et al.: Central serous chorioretinopathy complicating systemic lupus erythematosus: a case series. Clin Exper Ophthalmol 2000, 28:309–313.
Cambiaggi A: Unusual ocular lesions in a case of systemic lupus erythematosus. AMA Arch Ophthalmol 1957, 57:451–453.
Jabs DA, Miller NR, Newman SA, et al.: Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol 1986, 104:564–546.
Giorgi D, Balacco Gabrieli C: Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis and a review of the literature and proposed ophthalmological criteria for APS diagnosis. Clin Rheumatol 1999, 18:124–131.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Young, S. Ocular involvement in connective tissue disorders. Curr Allergy Asthma Rep 5, 323–326 (2005). https://doi.org/10.1007/s11882-005-0076-y
Issue Date:
DOI: https://doi.org/10.1007/s11882-005-0076-y